Andrew E. Kersey, president and chief executive officer of CASMED stated, “Establishing a multi-year agreement with this prestigious healthcare system is directly in line with our strategy to target the sale of products directly to hospital purchasing groups. This strategy is aimed at improving service to the customer and increasing CASMED’s margins. Initial hospital conversions are already underway with positive feedback from both the clinical end users and biomedical groups within these facilities.”
